Our News

Sciencewerke News

A look at IgA responses of COVID-19 patient sera to known human autoantigens.

Studies report a link between COVID-19 disease severity and autoimmunity, with growing evidence showing development of autoantibodies as a result of long-lasting or life threatening cases of SARS-CoV-2 infection. Discover the new PEPperCHIPĀ® Autoimmune Human Epitope Microarray with 3,723 human B-cell epitopes associated with autoimmune diseases. The microarray enables you to:

  • Monitor autoantibody development in COVID-19 patient sera.
  • Identify autoantibody responses after COVID-19 infection
  • Investigate autoantibody responses before and after COVID-19 vaccination.
  • Correlate IgG or IgA autoantibodies with disease progression.
  • Analyze autoantibody responses in animal models on the epitope level.
  • Back  
  • Top